Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Abstract: In this article, the tracking control problem of event-triggered multigradient recursive reinforcement learning is investigated for nonlinear multiagent systems (MASs). Attention is focused ...

Not everyone can declare themselves “benevolent dictator for life” of a company, but such was the nature of Guido van Rossum, the Dutch programmer who invented an entire programming language from ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Le tribunal administratif de Lyon vient de confirmer la sanction d’exclusion temporaire d’un jour prononcée à l’encontre d’un encadrant de la territoriale à la suite d’altercations avec un subordonné.

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Are you ahead, or behind on retirement? SmartAsset's free ...

https://www.riteshmodi.com - Data Scientist, AI and blockchain expert with proven open-source solutions on MLOps, LLMOps and GenAIOps. https://www.riteshmodi.com - Data Scientist, AI and blockchain ...

Recursion Pharmaceuticals is a pioneer in AI-powered drug discovery but faces challenges in monetizing its innovations and aligning management's vision with sustainable revenue paths. The company's ...

Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company, visit the Nasdaq MarketSite in Times Square on January 22 to ring the Nasdaq Opening Bell and celebrate the “Era of ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.